Apollo Proton Cancer Centre (APCC) has recently launched the Apollo Rectal Cancer (ARC) Programme, India's pioneering approach dedicated to rectal cancer management. With a focus on rectal preservation and powered by advanced technologies including chemoradiotherapy, proton therapy, and robotic surgery, the ARC programme aims to revolutionise the treatment of rectal cancer in the country. This unique initiative addresses the specialised needs of rectal cancer patients, providing comprehensive and multidisciplinary care to ensure the best possible outcomes.

The ARC programme centre was inaugurated by Dr Prathap C Reddy, Founder-Chairman, Apollo Hospitals Enterprise Ltd (AHEL), in the presence of Harshad Reddy, Director - Group Oncology & International (AHEL). The programme will be led by Dr Venkatesh Munikrishnan (Lead), Consultant Colorectal & Robotic Surgeon,  Dr Senthil Ganapathi, Senior Consultant Colorectal Surgeon, Dr Sudeepta Kumar Swain, Consultant, Surgical  Gastroenterology and  Dr Bala Murugan Srinivasan, Consultant- Surgical  Gastroenterology.

The ARC Programme sets the stage for rectal cancer management as India's only quaternary care centre for rectal cancer, offering an integrated multidisciplinary care for rectal cancer for patients from the Indian subcontinent and afar.

Taking a 360-degree approach, the programme addresses the spectrum of rectal cancer complexities, including significant polyps, early rectal cancer, organ preservation, robotic rectal cancer surgery, and the treatment of peritoneal surface malignancies with heated intraperitoneal chemotherapy (HIPEC).